시장보고서
상품코드
1429683

세계의 수의용 의약품 시장 보고서(2024년)

Veterinary Pharmaceuticals Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

수의용 의약품 시장 규모는 향후 몇 년 동안 큰 폭으로 성장할 것으로 예상됩니다. 2028년에는 7.3%의 연평균 복합 성장률(CAGR)로 465억 4,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 반려동물 소유자 증가, 인구 증가, 가처분 소득 증가, 도시화, 반려동물 보험의 보급 확대, 정부 지원 등의 요인으로 인해 시장을 견인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 동물 치료를 위한 줄기세포 치료에 대한 관심, 항생제 내성 문제를 해결하기 위한 수의용 의약품에 나노기술 적용, 씹을 수 있는 정제 개발, COVID-19의 영향을 완화하기 위한 원격 의료 플랫폼 활용, 첨단 백신 개발, 슈퍼 콤보 기생충 구제제에 대한 관심, 서브유닛 및 바이러스 입자(VLP) 기반 백신 활용, 전략적 파트너십 및 공동연구에 대한 집중 등이 있습니다.

수의용 의약품 시장은 동물 질병의 유병률이 눈에 띄게 증가함에 따라 주도하고 있습니다. 가축과 반려동물 모두 질병 발생률이 급격히 증가함에 따라 효과적인 치료를 위한 의약품이 필요합니다. 중요한 예로, Banfield State of Pet Health Report에 따르면 반려견의 당뇨병 발병률이 10,000마리당 13.1건에서 23.6건으로 79.7% 증가한 것으로 보고됐습니다. 이 질병의 확산 증가는 수의용 의약품에 대한 수요 증가를 강조하고 있습니다.

반려동물을 기르는 추세가 증가함에 따라 가까운 미래에 수의용 의약품 시장의 성장이 촉진될 것으로 예상됩니다. 반려동물을 소유하는 것은 가축의 복지에 대한 개인 또는 가정의 법적, 윤리적 책임을 수반합니다. 반려동물 소유자의 수가 증가함에 따라 다양한 종, 품종 및 건강 상태에 대한 특수 의약품에 대한 수요도 그에 따라 증가하고 있습니다. 미국 반려동물 제품 협회의 보고서에 따르면 2023년에는 미국 가구의 66%, 2022년에는 62%, 2022년에는 44.5%의 가구가 개를, 29%는 고양이를 키울 것으로 예상했습니다. 반려동물 소유는 수의용 의약품 시장의 주요 원동력입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 수의용 의약품 시장, 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 수의용 백신
  • 수의용 항생제
  • 수의용 구충제
  • 기타 유형
  • 세계의 수의용 의약품 시장, 동물 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 반려동물
  • 가축
  • 세계의 수의용 의약품 시장, 백신별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 불활화 백신
  • 약독화 백신
  • 재조합 백신
  • 세계의 수의용 의약품 시장, 투여 경로별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 경구
  • 기타 투여 경로
  • 세계의 수의용 의약품 시장, 최종사용자별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 동물 병원
  • 수의 클리닉
  • 약국과 드럭스토어

제7장 지역 및 국가 분석

  • 세계의 수의용 의약품 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 수의용 의약품 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 수의용 의약품 시장 경쟁 상황
  • 수의용 의약품 시장 기업 개요
    • Zoetis Inc
    • Merck &Co., Inc
    • Boehringer Ingelheim International Gmb
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale

제31장 기타 주요 및 혁신적인 기업

  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Kyoritsu Seiyaku Corporation
  • National Meditek
  • Fartovet Industry Limited
  • Hebei Chengshengtang Animal Pharmaceutical
  • Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd
  • Vvaan Lifesciences Private Limited
  • Century Pharmaceuticals Limited
  • Cargill India Pvt. Ltd.
  • Jurox Pty Ltd
  • Bayer
  • Veteq

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

Veterinary pharmaceuticals constitute a category of pharmacologically active drugs employed to control, prevent, and treat diseases in animals. These drugs exhibit their effects upon administration to animals and undergo rapid breakdown into active ingredients, primarily facilitated by small intestine metabolism.

The primary types of veterinary pharmaceuticals encompass veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other varieties. Veterinary vaccines offer protection against one or more diseases, mitigating their severity or preventing them altogether. The routes of administration include oral and various other routes tailored to different animal types, including companion animals and livestock. The vaccines themselves are classified into categories such as inactivated vaccines, attenuated vaccines, recombinant vaccines, and others, and they are supplied by diverse end-users, including veterinary hospitals, veterinary clinics, pharmacies, and drug stores.

The veterinary pharmaceuticals research report is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals statistics, including veterinary pharmaceuticals industry global market size, regional shares, competitors with veterinary pharmaceuticals share, detailed veterinary pharmaceuticals segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. This veterinary pharmaceuticals research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmaceuticals market size has grown strongly in recent years. It will grow from $32.53 billion in 2023 to $35.05 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The expansion observed in the historical period can be attributed to factors such as the increased pet population, elevated overall spending by individuals on pets, the growing penetration of e-commerce platforms promoting online pharmacies, the growth of emerging markets, increasing government initiatives, and the heightened prevalence of diseases.

The veterinary pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $46.54 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period can be attributed to factors such as the increasing ownership of pets, population growth, rising disposable income, urbanization, the growing penetration of pet insurance, and government support, which will drive the market. Major trends in the forecast period include a focus on stem cell therapy for treating animals, the application of nanotechnology in veterinary medicines to address antibiotic resistance, the development of chewable tablets, the use of telemedicine platforms to mitigate the impact of COVID-19, the development of advanced vaccines, a focus on super-combo parasiticides, the utilization of subunit and virus-such as particle (VLP)-based vaccines, and a concentration on strategic partnerships and collaborations.

The veterinary pharmaceuticals market is being driven by a notable increase in the prevalence rate of diseases among animals. The upsurge in disease incidence in both livestock and companion animals necessitates medicines for effective treatment. A significant example is the reported 79.7% increase in diabetes cases in dogs, from 13.1 cases per 10,000 to 23.6 cases, according to the Banfield State of Pet Health Report. This rise in disease prevalence underscores the heightened demand for veterinary pharmaceuticals.

The growing trend of pet ownership is anticipated to propel the growth of the veterinary pharmaceuticals market in the foreseeable future. Pet ownership involves the legal and ethical responsibility of individuals or households for the well-being of domesticated animals. As the number of pet owners increases, there is a corresponding rise in demand for specialized medications catering to various species, breeds, and health conditions. In 2023, a report from the American Pet Products Association Inc. revealed that 66% of US households owned pets, compared to 62% in 2022, with dogs being owned by 44.5% and cats by 29% of households in 2022. This surge in pet ownership is a key driver of the veterinary pharmaceuticals market.

Government agencies such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) regulate the veterinary pharmaceuticals market. Notably, the EU agencies require 6 to 12 months for the approval of veterinary medicinal products, and all parts of the registration dossier must be submitted together. In contrast, the US-FDA accepts phased submissions and assesses each technical section for 6 months. Efficient planning, effective communication, and careful consideration of regulatory policies are crucial for manufacturers in navigating the approval process and minimizing costs and timelines.

The emergence of generic drugs for animal care is a notable trend in the veterinary pharmaceuticals market. The cost-effectiveness of generic drugs has led to increased adoption by pet owners, with the FDA approving 22 generic animal drugs for cats and dogs. A survey of 520 veterinarians revealed that around 80% are using generic drugs to save pet owners money. Despite the lower profit margins compared to branded drugs, veterinarians are favoring generic drugs for their economic benefits.

Major companies in the veterinary pharmaceuticals market are innovating by introducing new products such as molidustat oral suspensions to expand customer bases and increase revenue. Elanco Animal Health Incorporated, for example, launched Varenzin-CA1 (molidustat oral suspension), the first medication for managing non-regenerative anemia in cats with chronic kidney disease (CKD). This needle-free oral suspension allows at-home administration, receiving provisional approval from the FDA. The unique features of Varenzin-CA1 showcase a commitment to providing novel therapies and expanding treatment options for animals with specific conditions or illnesses lacking effective treatments.

Major companies operating in the veterinary pharmaceuticals market report are Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, National Meditek, Fartovet Industry Limited, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co .Ltd., Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd., Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, VitOMEK LCC, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Bond Vet, trifecta Pharmaceuticals USA LLC., Trifecta Pharmaceuticals USA LLC., Bio-Synthesis Inc., Small Door Veterinary, Fuzzy, Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd., Maure, Peru Animal Hospital, Miami County Veterinary Clinic, Cindy Fouts, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Physio Evolution, Herzliya Veterinary Hospital, Oron Veterinary Center, Dr Aviram Ezra - Veterinarian, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Aesthetics Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., M S J Afro Agro Pharmacy, Global Vet (U) Ltd

North America was the largest region in the veterinary pharmaceuticals market in 2023. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Pharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Veterinary Vaccines; Veterinary Antibiotics; Veterinary Parasiticides; Other Veterinary Pharmaceuticals
  • 2) By Type Of Animal: Livestock; Companion Animals
  • 3) By Type Of Vaccine: Inactivated Vaccines; Attenuated Vaccines; Recombinant Vaccines; Other Vaccines
  • 4) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration
  • 5) By End User: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores
  • Companies Mentioned: Zoetis Inc; Merck & Co., Inc; Boehringer Ingelheim International Gmb; Elanco Animal Health Incorporated; Ceva Sante Animale
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Pharmaceuticals Market Characteristics

3. Veterinary Pharmaceuticals Market Trends And Strategies

4. Veterinary Pharmaceuticals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Veterinary Pharmaceuticals Market Size and Growth

  • 5.1. Global Veterinary Pharmaceuticals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Veterinary Pharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Veterinary Pharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Pharmaceuticals Market Segmentation

  • 6.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Veterinary Vaccines
  • Veterinary Antibiotics
  • Veterinary Parasiticides
  • Other Types
  • 6.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Companion Animals
  • Livestock Animals
  • 6.3. Global Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • 6.4. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Other Routes Of Administration
  • 6.5. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies And Drug Stores

7. Veterinary Pharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Pharmaceuticals Market

  • 8.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Pharmaceuticals Market

  • 9.1. China Veterinary Pharmaceuticals Market Overview
  • 9.2. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Pharmaceuticals Market

  • 10.1. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Pharmaceuticals Market

  • 11.1. Japan Veterinary Pharmaceuticals Market Overview
  • 11.2. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Pharmaceuticals Market

  • 12.1. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Pharmaceuticals Market

  • 13.1. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Pharmaceuticals Market

  • 14.1. South Korea Veterinary Pharmaceuticals Market Overview
  • 14.2. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Pharmaceuticals Market

  • 15.1. Western Europe Veterinary Pharmaceuticals Market Overview
  • 15.2. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Pharmaceuticals Market

  • 16.1. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Pharmaceuticals Market

  • 17.1. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Pharmaceuticals Market

  • 18.1. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Pharmaceuticals Market

  • 19.1. Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Pharmaceuticals Market

  • 20.1. Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Pharmaceuticals Market

  • 21.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
  • 21.2. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Pharmaceuticals Market

  • 22.1. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Pharmaceuticals Market

  • 23.1. North America Veterinary Pharmaceuticals Market Overview
  • 23.2. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Pharmaceuticals Market

  • 24.1. USA Veterinary Pharmaceuticals Market Overview
  • 24.2. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Pharmaceuticals Market

  • 25.1. Canada Veterinary Pharmaceuticals Market Overview
  • 25.2. Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Pharmaceuticals Market

  • 26.1. South America Veterinary Pharmaceuticals Market Overview
  • 26.2. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Pharmaceuticals Market

  • 27.1. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Pharmaceuticals Market

  • 28.1. Middle East Veterinary Pharmaceuticals Market Overview
  • 28.2. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Pharmaceuticals Market

  • 29.1. Africa Veterinary Pharmaceuticals Market Overview
  • 29.2. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Pharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Pharmaceuticals Market Competitive Landscape
  • 30.2. Veterinary Pharmaceuticals Market Company Profiles
    • 30.2.1. Zoetis Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co., Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boehringer Ingelheim International Gmb
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Elanco Animal Health Incorporated
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Ceva Sante Animale
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Veterinary Pharmaceuticals Market Other Major And Innovative Companies

  • 31.1. Virbac SA
  • 31.2. Dechra Pharmaceuticals PLC
  • 31.3. Vetoquinol S.A.
  • 31.4. Phibro Animal Health Corporation
  • 31.5. Kyoritsu Seiyaku Corporation
  • 31.6. National Meditek
  • 31.7. Fartovet Industry Limited
  • 31.8. Hebei Chengshengtang Animal Pharmaceutical
  • 31.9. Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd
  • 31.10. Vvaan Lifesciences Private Limited
  • 31.11. Century Pharmaceuticals Limited
  • 31.12. Cargill India Pvt. Ltd.
  • 31.13. Jurox Pty Ltd
  • 31.14. Bayer
  • 31.15. Veteq

32. Global Veterinary Pharmaceuticals Market Competitive Benchmarking

33. Global Veterinary Pharmaceuticals Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

35. Veterinary Pharmaceuticals Market Future Outlook and Potential Analysis

  • 35.1 Veterinary Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Pharmaceuticals Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제